Efficacy and Safety of Dulaglutide in Older Patients: A post hoc Analysis of the REWIND trial

CONTEXT: Dulaglutide reduced major adverse cardiovascular events (MACE) in the Researching Cardiovascular Events with a Weekly INcretin in Diabetes (REWIND) trial. Its efficacy and safety in older vs younger patients have not been explicitly analyzed. OBJECTIVE: This work aimed to assess efficacy an...

Descripción completa

Detalles Bibliográficos
Autores principales: Riddle, Matthew C, Gerstein, Hertzel C, Xavier, Denis, Cushman, William C, Leiter, Lawrence A, Raubenheimer, Peter J, Atisso, Charles M, Raha, Sohini, Varnado, Oralee J, Konig, Manige, Lakshmanan, Mark, Franek, Edward
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Clinical Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8063250/
https://www.ncbi.nlm.nih.gov/pubmed/33537745
http://dx.doi.org/10.1210/clinem/dgab065

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8063250/
https://www.ncbi.nlm.nih.gov/pubmed/33537745
http://dx.doi.org/10.1210/clinem/dgab065

Ejemplares similares